The functionality of the differentiated HLCs was rigorously assessed using several in vitro assays
[59] showed the excellent efficacy of GLP-1/GIP/glucagon receptor triagonists in reversing fatty liver disease in mice
Ideally, each drug is compounded specifically for what one patient needs
92%) found by Gier et al
In order to adjust for confounders, the following covariate variables were selected as the independent variable: age, race, ethnicity, sex, BMI, history of chronic kidney disease (CKD), history of congestive heart failure (CHF), history of diabetes, history of gastric surgery, history of gastroparesis, whether bowel prep was used (e.g., underwent same day EGD-flexible sigmoidoscopy or EGD-colonoscopy), history of GLP-1RA use, and other medications known to contribute to delayed gastric emptying